AtriCure, Inc. (ATRC) Release: First Patient Successfully Treated With Innovative Procedure Focused on Most Challenging Atrial Fibrillation Patient Segment

9/18/2012 9:01:03 AM

NORFOLK, Va.--(BUSINESS WIRE)--Sentara Heart Hospital is leading the way in an innovative Atrial Fibrillation (AF) procedure for what is typically the most difficult to treat or persistent, forms of AF. This past week, surgeons and cardiologists at Sentara Heart Hospital were the first in the world to begin performing surgeries in the Dual Epicardial Endocardial Persistent Atrial Fibrillation (AF) Study (Staged DEEP) feasibility trial. The first procedure was performed by cardiothoracic surgeon collaborator Jonathan Philpott, M.D., director of the Sentara Atrial Fibrillation Surgery Program and cardiac electrophysiologist collaborator Ian Woollett, M.D. of Cardiovascular Associates.

Read at BioSpace.com

Read Article at

Related Companies

News Categories

• BioSpace.com

• AtriCure, Inc.

• Medical Devices

• Medical Dev. & Diag. - Research